It has been proposed that the immunotherapeutic role of CD8+ MAIT cells in lung cancer is mediated, at least in part, by interactions with classical and non-classical monocytes via the CXCL16–CXCR6 axis [68,69]. This evidence concerns the gene CD8A and lung carcinoma.